Effect of lysosomal cationic proteins from polymorphonuclear leukocytes upon the fibrinogen and fibrinolysis system.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D005337:Fibrin; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen; D005342:Fibrinolysis; D006863:Hydrogen-Ion Concentration; D007962:Leukocytes / Q000032:analysis*; D008247:Lysosomes / Q000032:analysis*; D010447:Peptide Hydrolases / Q000302:isolation & purification / Q000378:metabolism; D010958:Plasminogen / Q000494:pharmacology; D010960:Plasminogen Activators / Q000302:isolation & purification / Q000494:pharmacology; D011480:Protease Inhibitors; D011506:Proteins / Q000494:pharmacology*; D011817:Rabbits; D014361:Trypsin Inhibitors / Q000494:pharmacology
D000614:Aminocaproates; D005338:Fibrin Fibrinogen Degradation Products; D011480:Protease Inhibitors; D011506:Proteins; D014361:Trypsin Inhibitors; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D010447:Peptide Hydrolases; D010960:Plasminogen Activators